ECG Resting System Market Size & Share, by Device Type (Fixed ECG Systems, Mobile ECG Systems); Connectivity; End user; Application; Technology; Lead Type; Distribution Channel - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2026-2035

ECG Resting System Market - Regional Analysis

North America Market Insights

North America is predicted to capture the largest revenue share of 39.7% in the ECG resting system market by the end of 2035. The high healthcare expenditure and the presence of major market players are the key factors behind the region’s leadership. In December 2024, HeartBeam reported that it had received FDA 510(k) clearance for its at-home, cable-free ECG device, which is designed for arrhythmia assessment that records high-fidelity heart signals from three angles and syncs with a mobile app to send data to physicians in real time.

The U.S. is augmenting its leadership in the regional ECG resting system market on account of increased focus on preventive healthcare and substantial investments in healthcare innovation.  In July 2024, Octagos Health secured over USD 43 million in a Series B funding round, which was led by Morgan Stanley Expansion Capital, with continued support from Mucker Capital and other investors. Further, the investment will accelerate the company's mission to enhance cardiac care through advanced artificial intelligence and comprehensive patient monitoring services.

There is a huge exposure for Canada in the regional market owing to the ever-increasing healthcare expenditure, rising awareness about cardiovascular diseases, and a growing geriatric population. In this regard, Health Canada stated that the Government of Canada, through CIHR, has invested USD 5 million to establish the Canadian Heart Function Alliance, a national research network that is focused on improving heart failure prevention, diagnosis, treatment, and care, hence suitable for standard market growth.

APAC Market Insights

The Asia Pacific region is identified as the fastest-growing region in the ECG resting system market over the discussed timeframe. The region’s upliftment in this field is effectively attributed to the widespread adoption when compared to Holter and stress ECG monitors. On the other hand, healthcare investments in this region are readily increasing, which is supporting strong momentum in the region. Furthermore, technological innovations, especially in terms of portable and wireless ECG models, are also boosting the market growth, positioning the region as the predominant leader in this field.

China represents the largest and influential landscape in the regional market, which is propelled by the rapid modernization of healthcare infrastructure and digital health adoption. In April 2025, Beneware Medical reported that it successfully showcased its latest innovations at the 91st Shanghai CMEF, showcasing its products such as the Digital Electrocardiograph, Exercise Stress Test System, and Remote ECG Network. The company also displayed a range of cardiac and pulmonary diagnostic devices, drawing attention from medical institutions and suppliers.

India is experiencing rapid growth in the ECG resting system market on account of strong government support and heightened demand in both urban and semi-urban medical settings. For instance, in February 2024, SCHILLER announced that it has launched the CARDIOVIT FT-2, which is a portable touchscreen ECG device designed for advanced hospital use, featuring a seamless, easy-to-clean interface and an optional thermal printer. The device is built on a security-hardened Linux kernel, and it offers strong cybersecurity, extensive connectivity with hospital IT systems, and supports both paper-based and paperless workflows.

Key Statistics on the Burden and Economic Impact of Cardiovascular Diseases (CVDs) in India as of June 2024

Source: NIH

Europe Market Insights

Europe has a huge potential in the market, which is considered to be the second largest landscape in this field. The increasing prevalence of cardiovascular diseases and the growing emphasis on preventive healthcare are the key reasons behind the leadership. For instance, in 2025, Norav Medical announced that its entire ECG product portfolio had received CE marking under the European Medical Device Regulation (MDR) EU 2017/745, reinforcing its suitability for clinical, hospital, and research settings.

Germany stands at the forefront of growth in the regional ECG resting system sector due to its advanced healthcare infrastructure and strong emphasis on early cardiovascular diagnostics, which contributes to a high adoption rate of resting ECG systems. Besides, these systems are extensively utilized in both public and private hospitals, which is also supported by the country’s leadership in medical technology manufacturing and investment in telecardiology services, hence positively influencing market growth.

The U.K. is gaining momentum in the ECG resting system industry owing to the notable rise in the adoption of resting ECG systems, particularly within the National Health Service (NHS). In June 2025, the country’s parliament noted that the country’s government aims to reduce premature deaths from heart disease and strokes by 25% in 10 years. Following a critical NHS review, a new 10-year plan focuses on shifting care from hospitals to communities, increasing digital health tools, and expanding local diagnostics.

Under-75 Cardiovascular Disease Mortality Rate per 100,000 Population - U.K.

Source: Lords Library